← Eichor
Study identifier: NCT05971329 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease

Condition: Radiculopathy, Cervical · Myelopathy Cervical · Neurological Abnormality  ·  Sponsor: Zetagen Therapeutics, Inc

PhaseNA
Planned participants10
Who can joinAll sexes, 22 Years to 75 Years
Healthy volunteersYes

About this study

The goal of this pilot clinical trial is to test the safety and preliminary performance of the ZetaFuse Bone Graft in patient requiring fusion of the C3-C7 vertebral bones due to pain or loss of neurological function. Participants will be treated with ZetaFuse during surgical intervention to reduce pain and the loss of neurological function.

This description comes directly from the study's public registry record.

Talk to the study team

Julie Croft  ·  0882494788  ·  julie.croft@avancecro.com

Always discuss trial participation with your own doctor first.

Locations (2)

Prince of Wales Private HospitalRandwick, New South Wales, AustraliaRecruiting
Prince of Wales Public HospitalRandwick, New South Wales, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05971329